ALXA Financial Facts

Total operating expenses: 10.5M
Net loss attributable to Alexza common stockholders: -13.33M
See Full Income Statement

Total liabilities and stockholders' equity: 65.8M
Other comprehensive income: -1K
See Full Balance Sheet

Alexza Pharmaceuticals Inc. (ALXA) Earnings

  |   Expand Research on ALXA
Next EPS Date N/A EPS Growth Rate -61.9% *Last Qtr.
Average EPS % Beat Rate -127.1% Revenue Growth Rate -96.3% *Last Qtr.
Average % Move 1-Wk after EPS -11.9% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/7/14 Q214 -$0.34-$0.67 +$0.33$1.5M$2.24M N/A Details
11/6/13 Q313 -$0.72-$0.54 -$0.18$2.2M$1.98M N/A Details
8/8/13 Q213 -$0.21$0.09 -$0.30$40.84M$14.17M N/A Details
5/14/13 Q113 -$1.31-$0.45 -$0.86$729K$1M N/A Details
3/26/13 Q412 -$0.65N/A N/A $729K$1.88M N/A Details
11/7/12 Q312 -$0.52N/A N/A $729K$1.86M N/A Details
5/10/12 Q112 -$0.04-$0.08 +$0.04$1.88M$1.3M N/A Details
11/30/-1 Q411 -$0.13-$0.12 -$0.01$1.88M$5.8M N/A Details